Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward D Ball

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Blood|December 26, 2009
Increasing the punch of reduced-intensity transplantsEdward D Ball
Annals of Internal Medicine|December 4, 2003
Update in hematologyEdward D Ball
Leukemia Research|June 19, 2004
Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodiesLarisa Balaian, Edward D Ball
Experimental Hematology|January 29, 2005
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathwaysLarisa Balaian, Edward D Ball
Future Oncology (London, England)|March 8, 2017
What are the latest advancements in acute myeloid leukemia therapy?Aaron Goodman, Edward D Ball
Best Practice & Research. Clinical Haematology|November 30, 2010
Monoclonal antibodies in the treatment of hematologic malignancyEdward D Ball, H Elizabeth Broome
Experimental Hematology|October 27, 2004
Summary of the 12th international symposium on recent advances in stem cell transplantationEdward D Ball, Anthony D Ho
Cancer Treatment and Research|March 23, 2002
Development of allogeneic hematopoietic stem cell transplantation (HSCT)Januario E Castro, Edward D Ball
Expert Opinion on Biological Therapy|March 12, 2025
A review of antibody-based immunotherapy clinical trials for adult acute myeloid leukemia (AML): monoclonal antibodies (mAbs) and beyondKaitlyn C Dykes, Edward D Ball
Experimental Hematology|May 27, 2006
Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related SiglecsDzung H Nguyen, Edward D Ball, Ajit Varki
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Blood|December 26, 2009
Increasing the punch of reduced-intensity transplantsEdward D Ball
Annals of Internal Medicine|December 4, 2003
Update in hematologyEdward D Ball
Leukemia Research|June 19, 2004
Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodiesLarisa Balaian, Edward D Ball
Experimental Hematology|January 29, 2005
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathwaysLarisa Balaian, Edward D Ball
Future Oncology (London, England)|March 8, 2017
What are the latest advancements in acute myeloid leukemia therapy?Aaron Goodman, Edward D Ball
Best Practice & Research. Clinical Haematology|November 30, 2010
Monoclonal antibodies in the treatment of hematologic malignancyEdward D Ball, H Elizabeth Broome
Experimental Hematology|October 27, 2004
Summary of the 12th international symposium on recent advances in stem cell transplantationEdward D Ball, Anthony D Ho
Cancer Treatment and Research|March 23, 2002
Development of allogeneic hematopoietic stem cell transplantation (HSCT)Januario E Castro, Edward D Ball
Expert Opinion on Biological Therapy|March 12, 2025
A review of antibody-based immunotherapy clinical trials for adult acute myeloid leukemia (AML): monoclonal antibodies (mAbs) and beyondKaitlyn C Dykes, Edward D Ball
Experimental Hematology|May 27, 2006
Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related SiglecsDzung H Nguyen, Edward D Ball, Ajit Varki
Pageof 7